• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄牙视神经脊髓炎(NEMIPORT)——一项多中心研究。

Neuromyelitis optica in Portugal (NEMIPORT) - A multicentre study.

作者信息

Domingos Joana, Isidoro Luís, Figueiredo Rita, Brum Marisa, Capela Carlos, Barros Pedro, Santos Ernestina, Macário Maria do Carmo, Pinto Marques José, Pedrosa Rui, Vale José, Sá Maria José

机构信息

Centro Hospitalar do Porto - Hospital de Santo António, Department of Neurology, Largo Prof. Abel Salazar, 4099-001 Porto, Portugal.

Centro Hospitalar e Universitário de Coimbra, EPE, Department of Neurology, Avenida Bissaya Barreto, Praçeta Prof. Mota Pinto, 3000-075 Coimbra, Portugal.

出版信息

Clin Neurol Neurosurg. 2015 Jul;134:79-84. doi: 10.1016/j.clineuro.2015.04.001. Epub 2015 Apr 11.

DOI:10.1016/j.clineuro.2015.04.001
PMID:25965287
Abstract

BACKGROUND

Neuromyelitis Optica (NMO) is an inflammatory demyelinating disease of the CNS. There have been few epidemiologic studies on NMO, none in Portugal.

OBJECTIVE

To analyze the clinical, biological and MRI characteristics from a cohort of Portuguese patients who fulfilled the Wingerchuk 2006 NMO/NMOSD criteria. To identify and characterize those who had concomitant autoimmune disease or circulating autoantibodies.

METHODS

We performed an observational, retrospective, multicenter study in 5 Hospital Centers in Portugal.

RESULTS

Sixty-seven patients fulfilled the inclusion criteria. They were mainly Caucasian, 55 female. Median age at onset was 32.0 years and mean follow-up 7.4±6.0 years. Twenty-one patients were definite NMO and optic neuritis (ON) the most frequent initial presentation. Forty-six were classified as NMO spectrum disorders. The main subtypes were recurrent ON and single longitudinally extensive transverse myelitis. Twenty-four patients had positive AQP4-IgG. Twenty-three had other circulating autoantibodies. Fifteen out of 67 patients had concomitant autoimmune disease. There was a significant correlation between the presence of autoimmune disease and the positivity for AQP4-IgG. Five patients died, all definite NMO.

CONCLUSION

This is the first study about this rare disease in Portugal. Demographic features were similar to other studies. The existence of concomitant autoimmune disease was significantly associated with seropositivity for AQP4-IgG.

摘要

背景

视神经脊髓炎(NMO)是一种中枢神经系统炎性脱髓鞘疾病。关于NMO的流行病学研究较少,葡萄牙尚无此类研究。

目的

分析符合2006年Wingerchuk NMO/NMOSD标准的葡萄牙患者队列的临床、生物学和MRI特征。识别并描述伴有自身免疫性疾病或循环自身抗体的患者。

方法

我们在葡萄牙的5个医院中心进行了一项观察性、回顾性、多中心研究。

结果

67例患者符合纳入标准。他们主要为白种人,55例为女性。发病时的中位年龄为32.0岁,平均随访7.4±6.0年。21例为确诊的NMO,视神经炎(ON)是最常见的首发表现。46例被归类为NMO谱系障碍。主要亚型为复发性ON和单发纵向广泛横贯性脊髓炎。24例患者AQP4-IgG呈阳性。23例有其他循环自身抗体。67例患者中有15例伴有自身免疫性疾病。自身免疫性疾病的存在与AQP4-IgG阳性之间存在显著相关性。5例患者死亡,均为确诊的NMO。

结论

这是葡萄牙关于这种罕见疾病的第一项研究。人口统计学特征与其他研究相似。伴有自身免疫性疾病与AQP4-IgG血清阳性显著相关。

相似文献

1
Neuromyelitis optica in Portugal (NEMIPORT) - A multicentre study.葡萄牙视神经脊髓炎(NEMIPORT)——一项多中心研究。
Clin Neurol Neurosurg. 2015 Jul;134:79-84. doi: 10.1016/j.clineuro.2015.04.001. Epub 2015 Apr 11.
2
Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.视神经脊髓炎谱系疾病伴水通道蛋白 4 和髓鞘少突胶质细胞糖蛋白抗体:一项比较研究。
JAMA Neurol. 2014 Mar;71(3):276-83. doi: 10.1001/jamaneurol.2013.5857.
3
Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.视神经脊髓炎谱系障碍:荷兰水通道蛋白4免疫球蛋白(AQP4-IgG)与髓鞘少突胶质细胞糖蛋白免疫球蛋白(MOG-IgG)血清阳性病例的临床和磁共振成像特征比较
Eur J Neurol. 2016 Mar;23(3):580-7. doi: 10.1111/ene.12898. Epub 2015 Nov 22.
4
Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland.芬兰南部连续视神经炎患者的视神经脊髓炎和水通道蛋白-4(AQP4)自身抗体。
Acta Ophthalmol. 2014 Jun;92(4):387-91. doi: 10.1111/aos.12187. Epub 2013 Jun 15.
5
Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China.中国天津中枢神经系统脱髓鞘疾病患者的临床特征及血清抗水通道蛋白4抗体阳性情况
CNS Neurosci Ther. 2014 Jan;20(1):32-9. doi: 10.1111/cns.12156. Epub 2013 Jul 27.
6
Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.水通道蛋白-4 免疫球蛋白 G 阳性视神经脊髓炎谱系疾病中的短节段脊髓炎病变。
JAMA Neurol. 2015 Jan;72(1):81-7. doi: 10.1001/jamaneurol.2014.2137.
7
Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.香港华人特发性炎性脱髓鞘疾病中的视神经脊髓炎免疫球蛋白G
Eur J Neurol. 2009 Mar;16(3):310-6. doi: 10.1111/j.1468-1331.2008.02376.x.
8
Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.视神经脊髓炎谱系疾病伴髓鞘少突胶质细胞糖蛋白或水通道蛋白-4 抗体:阿尔及利亚患者的临床和辅助检查特征。
J Neurol Sci. 2017 Oct 15;381:240-244. doi: 10.1016/j.jns.2017.08.3254. Epub 2017 Aug 31.
9
[Neuromyelitis optica is a frequently seen inflammatory demyelinating disease].视神经脊髓炎是一种常见的炎性脱髓鞘疾病。
Ugeskr Laeger. 2013 May 6;175(19):1331-5.
10
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.视神经脊髓炎及相关疾病中的髓鞘少突胶质细胞糖蛋白免疫球蛋白G:50例患者的多中心研究。第2部分:流行病学、临床表现、影像学和实验室特征、治疗反应及长期预后
J Neuroinflammation. 2016 Sep 27;13(1):280. doi: 10.1186/s12974-016-0718-0.

引用本文的文献

1
Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis.AQP4 抗体相关 NMOSD 的性别比和发病年龄:综述和荟萃分析。
J Neurol. 2024 Aug;271(8):4794-4812. doi: 10.1007/s00415-024-12452-8. Epub 2024 Jul 3.
2
Clinical and prognostic aspects of patients with the Neuromyelitis Optica Spectrum Disorder (NMOSD) from a cohort in Northeast Brazil.巴西东北部队列中视神经脊髓炎谱系疾病(NMOSD)患者的临床和预后方面。
BMC Neurol. 2022 Mar 16;22(1):95. doi: 10.1186/s12883-022-02621-5.